Gating strategy of experiment using 30 min EdU pulses experiments in mOr2-Piwi1 juvenile polyps. by Eudald Pascual-Carreras (12115380)

Difference in patients’ outcomes between years 2022 and 2023. by Rawan T. Tafish (21736177)

Subjects:

Meropenem Consumption Across Quarters of 2022-2023: Defined Daily Dose (Blue Bars) and Antimicrobial Cost per Patient Day (Red Line). by Rawan T. Tafish (21736177)

Subjects:

Estimated Cost Savings and Expenditures During the Gradual Implementation of an AMS Program Across Quarters in 2022–2023. by Rawan T. Tafish (21736177)

Subjects:

Pattern of meropenem prescription expressed as DDD per 1000 across medical specialties: 2022-2023. by Rawan T. Tafish (21736177)

Subjects:

Quarterly Trends in DDD per 1000 Patient-Days and Statistical Comparisons for 2022–2023. by Rawan T. Tafish (21736177)

Subjects:

Descriptive Data of Meropenem Compliance Indicators, 2022–2023. by Rawan T. Tafish (21736177)

Subjects:

Cochran-Armitage Trend test for “Transfer/Discharge” outcome across the quarters of years 2022 and 2023. by Rawan T. Tafish (21736177)

Subjects:

Comparison of Overall Compliance by Clinical Improvement and Transfer/Discharge Outcomes (2022-2023). by Rawan T. Tafish (21736177)

Subjects:

Cochran-Armitage Trend test for “Clinical Improvement within 72 hours” outcome across the quarters of years 2022 and 2023. by Rawan T. Tafish (21736177)

Subjects:

Independent predictors of poor outcome. by Weiyin Lin (16319964)

Table 1_Microplastics in focus: a silent disruptor of liver health- a systematic review.docx by Zahra Beyzaei (9911886)

“…After removing duplicates, conducting dual-stage screening, and assessing quality using the Newcastle–Ottawa Scale, 25 studies met our predefined inclusion criteria. Seventeen studies using human liver-derived cell lines consistently reported oxidative stress, inflammation, apoptosis, mitochondrial dysfunction, and disturbances in lipid-metabolism in a size- and dose-dependent manner, with nanoplastics showing the highest toxicity. …”

Investigating the effects of ankle foot orthoses on electromyography in impaired populations: a systematic review by Sally Kenworthy (20873172)

“…<p>Despite ample evidence supporting ankle foot orthoses (AFOs) for enhancing ambulation in those with neuromuscular impairment, a prevalent belief among rehabilitation professionals is that AFO use may lead to disuse and reduced muscle activity of the lower leg. …”

Subacute Anthracycline-Related Cardiotoxicity in Adolescent and Young Adult Patients of Sarcoma: A Prospective Echocardiographic Study  by Efstratios Koutroumpakis (14393682)

“…<p dir="ltr">Adolescent and young adult patients aged 15 to 39 years with a diagnosis of sarcoma who were scheduled to receive high-dose Dox (≥300 mg/m²) at a single tertiary cancer center between 2018 and 2022 were prospectively enrolled. …”

Table 1_Effects of probiotics on heart failure: a systematic review and meta-analysis.docx by Zheqin Zhu (22786637)

“…</p>Methods<p>As of 9 September 2025, we searched eight major academic databases using a predefined protocol for data extraction and quality assessment. …”

Image 1_Effects of probiotics on heart failure: a systematic review and meta-analysis.tif by Zheqin Zhu (22786637)

“…</p>Methods<p>As of 9 September 2025, we searched eight major academic databases using a predefined protocol for data extraction and quality assessment. …”

Supplementary Material for: Novel Protocol for the Use of Advanced Hybrid Closed-Loop System in Adolescents Engaged in Contact Sports. by Gawrecki A. (19938060)

“…During the camp, daily insulin dose and basal/bolus ratio remained comparable with baseline, but the relative amount of automated bolus insulin decreased by 14.24±4.65% (p<0.0001). Conclusion: The predefined regimen, including a temporary target before and disconnection of AHCL during football training, was safe and may provide satisfactory glucose control in active adolescents with T1D. …”

Table 2_Factors influencing bone mineral density in hyperparathyroidism phenotypes: a prospective study.xlsx by Margot Giocondo (21435500)

“…</p>Results<p>According to predefined thresholds, 40.0% of patients experienced a significant BMD gain at the spine, 35.1% at the femur, 23.5% at the left hip, and 8.6% at the radius. …”

Table 1_Factors influencing bone mineral density in hyperparathyroidism phenotypes: a prospective study.xlsx by Margot Giocondo (21435500)

“…</p>Results<p>According to predefined thresholds, 40.0% of patients experienced a significant BMD gain at the spine, 35.1% at the femur, 23.5% at the left hip, and 8.6% at the radius. …”

Image 1_Practical utility of meropenem therapeutic drug monitoring: a systematic review of evidence for clinical application.pdf by Yi-Chang Zhao (14080107)

“…Adverse reactions showed a non-significant reduction (RR = 0.65; 95% CI: 0.38–1.11). …”